Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer.
Visonneau S, Cesano A, Porter DL, Luger SL, Schuchter L, Kamoun M, Torosian MH, Duffy K, Sickles C, Stadtmauer EA, Santoli D.
Visonneau S, et al. Among authors: torosian mh.
Clin Cancer Res. 2000 May;6(5):1744-54.
Clin Cancer Res. 2000.
PMID: 10815893
Clinical Trial.